Silphium Asset Management LTD Imago Bio Sciences, Inc. Transaction History

Silphium Asset Management LTD

  • $280 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jan 30, 2025
SELL
$0.0 - $36.01 $0 - $1.8 Million
-50,000 Closed
0 $0
Q4 2022

Jan 30, 2025
BUY
$15.03 - $35.96 $751,500 - $1.8 Million
50,000 New
50,000 $1.8 Billion

Others Institutions Holding IMGO

# of Institutions
2
Shares Held
19.3K
Call Options Held
0
Put Options Held
0
View Full List

About Imago BioSciences, Inc.

IMGO Quotes by TradingView
  • Ticker IMGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,741,600
  • Description
  • Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...
More about IMGO
Track This Portfolio

Track Silphium Asset Management LTD Portfolio

Follow Silphium Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silphium Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Silphium Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email